TrialHepatology communications2022

Combination of tofogliflozin and pioglitazone for NAFLD: Extension to the ToPiND randomized controlled trial.

Masato Yoneda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.